Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-16800CALL0 0210.81TRUE00
2025-05-16850CALL0 096TRUE00
2025-05-16900CALL0 082.85TRUE00
2025-05-169545.6CALL0 164.75TRUE00
2025-05-161000CALL0 0152.83TRUE00
2025-05-161050CALL0 065.65TRUE00
2025-05-1611031.9CALL0 188.43TRUE00
2025-05-1611529.5CALL0 177.44TRUE00
2025-05-1612024.7CALL0 171.78TRUE00
2025-05-1612521.8CALL0 161.67TRUE00
2025-05-1613017.1CALL0 168.17TRUE00
2025-05-161358.47CALL0 768.55TRUE00
2025-05-1614014.5CALL0 265.1TRUE00
2025-05-161450CALL0 064.23TRUE00
2025-05-1615017.29CALL0 759.42TRUE00
2025-05-1615510.9CALL0 256.52TRUE00
2025-05-161608.4CALL0 755.94TRUE00
2025-05-161657CALL0 1056.66FALSE00
2025-05-161705.1CALL4 9755.28FALSE5.10
2025-05-161756.43CALL0 254.16FALSE00
2025-05-161804.95CALL0 157.94FALSE00
2025-05-161853.6CALL0 655.93FALSE00
2025-05-161901.75CALL0 459.35FALSE00
2025-05-161951.3CALL0 161.44FALSE00
2025-05-162001.5CALL0 164.57FALSE00
2025-05-162100CALL0 074.42FALSE00
2025-05-162200CALL0 083.83FALSE00
2025-05-162300CALL0 092.57FALSE00
2025-05-162400.4CALL0 0100.24FALSE00
2025-05-16800PUT0 0175.99FALSE00
2025-05-16850PUT0 0162.66FALSE00
2025-05-16900PUT0 0150.08FALSE00
2025-05-16950PUT0 0138.13FALSE00
2025-05-161000PUT0 0126.75FALSE00
2025-05-161050PUT0 0116.46FALSE00
2025-05-161100PUT0 0106.52FALSE00
2025-05-161150PUT0 097.37FALSE00
2025-05-161200PUT0 089.29FALSE00
2025-05-161250PUT0 081.13FALSE00
2025-05-161300PUT0 076.03FALSE00
2025-05-161352.11PUT0 170.29FALSE00
2025-05-161402.91PUT0 165.18FALSE00
2025-05-161458.5PUT0 166.03FALSE00
2025-05-161506PUT0 3063.67FALSE00
2025-05-161558.4PUT0 1460.11FALSE00
2025-05-161600PUT0 057.47FALSE00
2025-05-1616511.4PUT0 759.17TRUE00
2025-05-161700PUT0 058.58TRUE00
2025-05-161750PUT0 059.59TRUE00
2025-05-161800PUT0 057.79TRUE00
2025-05-161850PUT0 057.11TRUE00
2025-05-161900PUT0 060.04TRUE00
2025-05-1619549.2PUT0 159.66TRUE00
2025-05-1620070.8PUT0 058.21TRUE00
2025-05-162100PUT0 095.8TRUE00
2025-05-1622078PUT0 0106.69TRUE00
2025-05-1623088PUT0 0116.77TRUE00
2025-05-162400PUT0 0126.19TRUE00
2025-06-20500CALL0 0204.17TRUE00
2025-06-205583CALL0 1188.15TRUE00
2025-06-20600CALL0 0116.37TRUE00
2025-06-20650CALL0 0101.58TRUE00
2025-06-207046CALL0 1101.32TRUE00
2025-06-207565.6CALL0 180.92TRUE00
2025-06-20800CALL0 082.99TRUE00
2025-06-20850CALL0 066.98TRUE00
2025-06-209056.8CALL0 0114.27TRUE00
2025-06-20950CALL0 058.85TRUE00
2025-06-2010047CALL0 269.81TRUE00
2025-06-2010543.6CALL0 162.96TRUE00
2025-06-2011023CALL0 665.12TRUE00
2025-06-2011538.2CALL0 260.48TRUE00
2025-06-2012023.09CALL0 358.48TRUE00
2025-06-201250CALL0 057.39TRUE00
2025-06-2013041.25CALL0 955.17TRUE00
2025-06-201357.5CALL0 656.16TRUE00
2025-06-2014012.58CALL0 20754.2TRUE00
2025-06-2014529.15CALL0 753.94TRUE00
2025-06-2015011.93CALL0 353.75TRUE00
2025-06-201558.1CALL0 1251.92TRUE00
2025-06-2016013.5CALL3 10150.62TRUE13.50
2025-06-201656.95CALL0 249.34FALSE00
2025-06-201700CALL0 049.86FALSE00
2025-06-201755.3CALL0 447.18FALSE00
2025-06-201806.8CALL0 145949.24FALSE00
2025-06-201855.4CALL0 1047.4FALSE00
2025-06-201901.65CALL0 147.55FALSE00
2025-06-201952.55CALL0 146.08FALSE00
2025-06-202002CALL0 146.62FALSE00
2025-06-202101.3CALL0 249.18FALSE00
2025-06-202200CALL0 053.37FALSE00
2025-06-202300.65CALL0 857.85FALSE00
2025-06-202400.7CALL0 462.39FALSE00
2025-06-20500PUT0 0174.41FALSE00
2025-06-20550PUT0 0161.19FALSE00
2025-06-20600.25PUT0 2149.2FALSE00
2025-06-20650.3PUT0 2138.22FALSE00
2025-06-20700.45PUT0 1128.08FALSE00
2025-06-20750PUT0 0118.67FALSE00
2025-06-20800PUT0 0109.86FALSE00
2025-06-20850PUT0 0102.08FALSE00
2025-06-209011.3PUT0 094.69FALSE00
2025-06-20951.4PUT0 587.64FALSE00
2025-06-201000PUT0 081.65FALSE00
2025-06-2010511PUT0 075.79FALSE00
2025-06-201104.98PUT0 170.97FALSE00
2025-06-201153.7PUT0 3065.49FALSE00
2025-06-201203.05PUT0 132061.03FALSE00
2025-06-201254.05PUT0 5158.71FALSE00
2025-06-2013010.1PUT0 2757.75FALSE00
2025-06-2013514.7PUT0 558.92FALSE00
2025-06-201405.65PUT0 20557.7FALSE00
2025-06-2014519.5PUT0 354.84FALSE00
2025-06-2015013.8PUT0 153.15FALSE00
2025-06-2015513.55PUT0 252.67FALSE00
2025-06-2016016.6PUT0 352.01FALSE00
2025-06-2016534.1PUT0 552.15TRUE00
2025-06-201700PUT0 050.73TRUE00
2025-06-201750PUT0 049.12TRUE00
2025-06-201800PUT0 049.5TRUE00
2025-06-201850PUT0 049.55TRUE00
2025-06-201900PUT0 049.28TRUE00
2025-06-201950PUT0 048.47TRUE00
2025-06-202000PUT0 048.36TRUE00
2025-06-2021066.4PUT0 27143.64TRUE00
2025-06-2022076.4PUT0 352.61TRUE00
2025-06-2023087.6PUT0 176.3TRUE00
2025-06-2024077.4PUT0 182.42TRUE00
2025-07-18700CALL0 066.65TRUE00
2025-07-18750CALL0 0116.03TRUE00
2025-07-18800CALL0 071.83TRUE00
2025-07-18850CALL0 069.41TRUE00
2025-07-18900CALL0 057.3TRUE00
2025-07-18950CALL0 052.55TRUE00
2025-07-1810052.4CALL0 160.5TRUE00
2025-07-181050CALL0 059.45TRUE00
2025-07-181100CALL0 057.51TRUE00
2025-07-181150CALL0 054.98TRUE00
2025-07-181200CALL0 055.38TRUE00
2025-07-1812523.7CALL0 356.59TRUE00
2025-07-181300CALL0 055.91TRUE00
2025-07-181350CALL0 054.15TRUE00
2025-07-181406.7CALL0 12555.05TRUE00
2025-07-181450CALL0 054.13TRUE00
2025-07-181506.5CALL0 10052.62TRUE00
2025-07-181556.2CALL0 152.45TRUE00
2025-07-181604.52CALL0 251.95TRUE00
2025-07-181657.9CALL0 150.35FALSE00
2025-07-181700CALL0 050.27FALSE00
2025-07-181756CALL0 7548.44FALSE00
2025-07-181804.4CALL0 149.52FALSE00
2025-07-181855.01CALL0 148.74FALSE00
2025-07-181900CALL0 048.71FALSE00
2025-07-181950CALL0 047.41FALSE00
2025-07-182007CALL0 15047.46FALSE00
2025-07-182102.35CALL0 345.15FALSE00
2025-07-182201.45CALL0 146.39FALSE00
2025-07-182300.95CALL0 247.92FALSE00
2025-07-182400CALL0 051.01FALSE00
2025-07-18700PUT0 0105.23FALSE00
2025-07-18750PUT0 097.52FALSE00
2025-07-18800PUT0 090.74FALSE00
2025-07-18850PUT0 084.34FALSE00
2025-07-18901.16PUT0 578.63FALSE00
2025-07-18951.25PUT0 173.81FALSE00
2025-07-181001.75PUT0 569.05FALSE00
2025-07-181052.05PUT0 17562.71FALSE00
2025-07-181100PUT0 059.49FALSE00
2025-07-181157.2PUT0 158.31FALSE00
2025-07-181200PUT0 057.21FALSE00
2025-07-181255.3PUT0 155.9FALSE00
2025-07-181306.8PUT0 154.63FALSE00
2025-07-181350PUT0 054.68FALSE00
2025-07-181400PUT0 053.43FALSE00
2025-07-181450PUT0 053.71FALSE00
2025-07-1815010.55PUT0 152.35FALSE00
2025-07-181550PUT0 051.61FALSE00
2025-07-181600PUT0 051.06FALSE00
2025-07-1816531.3PUT0 150.35TRUE00
2025-07-181700PUT0 049.99TRUE00
2025-07-181750PUT0 050.83TRUE00
2025-07-181800PUT0 050.47TRUE00
2025-07-181850PUT0 049.54TRUE00
2025-07-181900PUT0 048.93TRUE00
2025-07-181950PUT0 047.71TRUE00
2025-07-182000PUT0 047.88TRUE00
2025-07-182100PUT0 043.75TRUE00
2025-07-182200PUT0 043.07TRUE00
2025-07-1823086.7PUT0 064.57TRUE00
2025-07-1824096.6PUT0 069.73TRUE00
2025-09-19750CALL0 060.83TRUE00
2025-09-19800CALL0 053.78TRUE00
2025-09-19850CALL0 058.28TRUE00
2025-09-19900CALL0 060.39TRUE00
2025-09-19950CALL0 058.8TRUE00
2025-09-191000CALL0 056.77TRUE00
2025-09-191050CALL0 055.8TRUE00
2025-09-191100CALL0 055.98TRUE00
2025-09-191150CALL0 055.81TRUE00
2025-09-191200CALL0 055.16TRUE00
2025-09-191250CALL0 055.29TRUE00
2025-09-191300CALL0 055.78TRUE00
2025-09-191350CALL0 054.32TRUE00
2025-09-191400CALL0 054.26TRUE00
2025-09-191450CALL0 053.1TRUE00
2025-09-191500CALL0 053.14TRUE00
2025-09-191550CALL0 052.55TRUE00
2025-09-191600CALL0 052.02TRUE00
2025-09-191650CALL0 051.93FALSE00
2025-09-191700CALL0 051.04FALSE00
2025-09-191750CALL0 051.08FALSE00
2025-09-191800CALL0 049.86FALSE00
2025-09-191850CALL0 049.36FALSE00
2025-09-191900CALL0 049.5FALSE00
2025-09-191950CALL0 048.75FALSE00
2025-09-192000CALL0 048.3FALSE00
2025-09-192100CALL0 048.54FALSE00
2025-09-192200CALL0 046.66FALSE00
2025-09-192300CALL0 047.29FALSE00
2025-09-192400CALL0 048.35FALSE00
2025-09-19750PUT0 076.22FALSE00
2025-09-19800PUT0 071.88FALSE00
2025-09-19850PUT0 067.67FALSE00
2025-09-19900PUT0 064.09FALSE00
2025-09-19950PUT0 061.38FALSE00
2025-09-191000PUT0 055.34FALSE00
2025-09-191050PUT0 057.15FALSE00
2025-09-191100PUT0 056.17FALSE00
2025-09-191150PUT0 056.23FALSE00
2025-09-191200PUT0 056.17FALSE00
2025-09-191250PUT0 055.71FALSE00
2025-09-191300PUT0 055.21FALSE00
2025-09-191350PUT0 054.65FALSE00
2025-09-191400PUT0 054.17FALSE00
2025-09-191450PUT0 053.75FALSE00
2025-09-191500PUT0 053.38FALSE00
2025-09-191550PUT0 052.66FALSE00
2025-09-191600PUT0 052.51FALSE00
2025-09-191650PUT0 052.02TRUE00
2025-09-191700PUT0 051.83TRUE00
2025-09-191750PUT0 051.22TRUE00
2025-09-191800PUT0 049.92TRUE00
2025-09-191850PUT0 048.69TRUE00
2025-09-191900PUT0 049.36TRUE00
2025-09-191950PUT0 048.43TRUE00
2025-09-192000PUT0 047.33TRUE00
2025-09-192100PUT0 048.43TRUE00
2025-09-192200PUT0 047.11TRUE00
2025-09-192300PUT0 047.58TRUE00
2025-09-192400PUT0 047.76TRUE00
2025-10-17750CALL0 061.44TRUE00
2025-10-17800CALL0 055.95TRUE00
2025-10-17850CALL0 057.99TRUE00
2025-10-17900CALL0 056.22TRUE00
2025-10-17950CALL0 054.96TRUE00
2025-10-171000CALL0 055.65TRUE00
2025-10-171050CALL0 054.2TRUE00
2025-10-171100CALL0 054.62TRUE00
2025-10-171150CALL0 054.24TRUE00
2025-10-171200CALL0 054.25TRUE00
2025-10-171250CALL0 054.51TRUE00
2025-10-171300CALL0 053.23TRUE00
2025-10-171350CALL0 053.49TRUE00
2025-10-171400CALL0 053.36TRUE00
2025-10-171450CALL0 052.77TRUE00
2025-10-171500CALL0 052.28TRUE00
2025-10-171550CALL0 052.35TRUE00
2025-10-171600CALL0 052.01TRUE00
2025-10-171650CALL0 051.2FALSE00
2025-10-1717020.28CALL0 050.48FALSE00
2025-10-1717518.45CALL0 049.99FALSE00
2025-10-1718016.1CALL0 249.49FALSE00
2025-10-1718514.3CALL0 149.23FALSE00
2025-10-171900CALL0 048.76FALSE00
2025-10-171950CALL0 048.33FALSE00
2025-10-172000CALL0 048.33FALSE00
2025-10-172100CALL0 047.47FALSE00
2025-10-172205.85CALL0 246.38FALSE00
2025-10-172302.3CALL0 245.65FALSE00
2025-10-172402.65CALL0 144.48FALSE00
2025-10-17750PUT0 070.74FALSE00
2025-10-17800PUT0 066.71FALSE00
2025-10-17850PUT0 062.8FALSE00
2025-10-17900PUT0 059.9FALSE00
2025-10-17950PUT0 057.7FALSE00
2025-10-171000PUT0 056.58FALSE00
2025-10-171054.07PUT0 155.41FALSE00
2025-10-171104.15PUT0 155.14FALSE00
2025-10-171150PUT0 054.77FALSE00
2025-10-171200PUT0 054.68FALSE00
2025-10-171257.29PUT0 254.68FALSE00
2025-10-171308.49PUT0 254.27FALSE00
2025-10-1713512.6PUT0 253.97FALSE00
2025-10-171400PUT0 053.75FALSE00
2025-10-171450PUT0 052.94FALSE00
2025-10-171500PUT0 052.49FALSE00
2025-10-171550PUT0 052.23FALSE00
2025-10-171600PUT0 051.8FALSE00
2025-10-1716535.75PUT0 151.34TRUE00
2025-10-171700PUT0 050.62TRUE00
2025-10-171750PUT0 050.32TRUE00
2025-10-171800PUT0 050.24TRUE00
2025-10-171850PUT0 049.11TRUE00
2025-10-171900PUT0 049.02TRUE00
2025-10-171950PUT0 048.84TRUE00
2025-10-172000PUT0 047.57TRUE00
2025-10-172100PUT0 046.71TRUE00
2025-10-172200PUT0 046.08TRUE00
2025-10-172300PUT0 046.36TRUE00
2025-10-172400PUT0 045.11TRUE00
2025-12-19600CALL0 067.02TRUE00
2025-12-19650CALL0 057.36TRUE00
2025-12-19700CALL0 058.85TRUE00
2025-12-197557.5CALL0 159.77TRUE00
2025-12-19800CALL0 057.57TRUE00
2025-12-19850CALL0 057.6TRUE00
2025-12-19900CALL0 054.88TRUE00
2025-12-19950CALL0 055.9TRUE00
2025-12-1910042.5CALL0 054.3TRUE00
2025-12-191050CALL0 055.01TRUE00
2025-12-191100CALL0 054.44TRUE00
2025-12-191150CALL0 054.63TRUE00
2025-12-1912024.2CALL0 053.7TRUE00
2025-12-1912543.45CALL0 3854.13TRUE00
2025-12-1913022CALL0 353.57TRUE00
2025-12-1913524.75CALL0 153.41TRUE00
2025-12-1914026.9CALL0 353.01TRUE00
2025-12-191450CALL0 052.52TRUE00
2025-12-1915024.8CALL0 352.37TRUE00
2025-12-1915525.63CALL0 051.4TRUE00
2025-12-1916026.8CALL1 7951.29TRUE26.80
2025-12-191650CALL0 050.7FALSE00
2025-12-1917020.5CALL0 8150.34FALSE00
2025-12-191750CALL0 050.02FALSE00
2025-12-1918012.3CALL0 1249.55FALSE00
2025-12-1918511.75CALL0 1549.42FALSE00
2025-12-1919010.75CALL0 148.86FALSE00
2025-12-1919510.4CALL0 6048.77FALSE00
2025-12-1920015CALL0 6248.46FALSE00
2025-12-1921014CALL0 1047.84FALSE00
2025-12-1922011.3CALL0 4547.38FALSE00
2025-12-192300CALL0 046.51FALSE00
2025-12-192405.2CALL0 146FALSE00
2025-12-19600PUT0 075.5FALSE00
2025-12-19650.8PUT0 170.95FALSE00
2025-12-19700PUT0 066.94FALSE00
2025-12-19750PUT0 063.61FALSE00
2025-12-19801.32PUT0 2060.76FALSE00
2025-12-19858.5PUT0 158.27FALSE00
2025-12-19902.79PUT0 2056.82FALSE00
2025-12-19950PUT0 055.2FALSE00
2025-12-191005PUT0 155.02FALSE00
2025-12-191055.2PUT0 155.2FALSE00
2025-12-191105.3PUT0 155.42FALSE00
2025-12-191150PUT0 054.75FALSE00
2025-12-1912015.5PUT0 254.46FALSE00
2025-12-1912515.5PUT0 154.59FALSE00
2025-12-1913014.3PUT0 154.15FALSE00
2025-12-1913515.25PUT0 153.48FALSE00
2025-12-191400PUT0 053.31FALSE00
2025-12-1914525.2PUT0 152.69FALSE00
2025-12-191500PUT0 052.09FALSE00
2025-12-191550PUT0 052.03FALSE00
2025-12-191600PUT0 051.66FALSE00
2025-12-191650PUT0 051.11TRUE00
2025-12-191700PUT0 050.88TRUE00
2025-12-191750PUT0 050.18TRUE00
2025-12-191800PUT0 049.52TRUE00
2025-12-1918554.71PUT0 16449.67TRUE00
2025-12-191900PUT0 048.97TRUE00
2025-12-191950PUT0 048.52TRUE00
2025-12-1920057.53PUT0 1648.03TRUE00
2025-12-1921071.8PUT0 147.54TRUE00
2025-12-1922080.5PUT0 247.06TRUE00
2025-12-192300PUT0 047.56TRUE00
2025-12-1924096.9PUT0 146.59TRUE00
2026-01-16750CALL0 058.91TRUE00
2026-01-16800CALL0 058.83TRUE00
2026-01-16850CALL0 055.32TRUE00
2026-01-16900CALL0 057.85TRUE00
2026-01-16950CALL0 057.11TRUE00
2026-01-161000CALL0 056.17TRUE00
2026-01-161050CALL0 055.28TRUE00
2026-01-161100CALL0 055.74TRUE00
2026-01-161150CALL0 056.41TRUE00
2026-01-161200CALL0 055.99TRUE00
2026-01-161250CALL0 056.13TRUE00
2026-01-161300CALL0 054.93TRUE00
2026-01-161350CALL0 055.12TRUE00
2026-01-161400CALL0 054.09TRUE00
2026-01-161450CALL0 053.99TRUE00
2026-01-1615041CALL0 853.2TRUE00
2026-01-1615529.9CALL0 052.77TRUE00
2026-01-1616030.5CALL0 152.1TRUE00
2026-01-1616518.2CALL0 1652.43FALSE00
2026-01-1617016.5CALL0 751.31FALSE00
2026-01-161750CALL0 050.9FALSE00
2026-01-1618019CALL0 550.91FALSE00
2026-01-161850CALL0 050.45FALSE00
2026-01-161900CALL0 050.24FALSE00
2026-01-161950CALL0 049.84FALSE00
2026-01-162000CALL0 049.62FALSE00
2026-01-162100CALL0 049.03FALSE00
2026-01-162200CALL0 048.44FALSE00
2026-01-162300CALL0 047.92FALSE00
2026-01-162404.4CALL0 147.81FALSE00
2026-01-16750PUT0 061.26FALSE00
2026-01-16800PUT0 058.86FALSE00
2026-01-16850PUT0 057.53FALSE00
2026-01-16900PUT0 056.85FALSE00
2026-01-16950PUT0 056.08FALSE00
2026-01-161000PUT0 056.58FALSE00
2026-01-161050PUT0 056.24FALSE00
2026-01-161100PUT0 056.21FALSE00
2026-01-161150PUT0 056.32FALSE00
2026-01-161200PUT0 055.44FALSE00
2026-01-161250PUT0 054.92FALSE00
2026-01-1613014.5PUT0 555.04FALSE00
2026-01-1613516.1PUT0 2754.92FALSE00
2026-01-1614017.95PUT0 1955.22FALSE00
2026-01-1614524.4PUT0 1454.05FALSE00
2026-01-1615022.5PUT0 353.67FALSE00
2026-01-161550PUT0 052.84FALSE00
2026-01-161600PUT0 052.44FALSE00
2026-01-1616526.5PUT0 1652.36TRUE00
2026-01-161700PUT0 051.66TRUE00
2026-01-161750PUT0 051.46TRUE00
2026-01-161800PUT0 051.23TRUE00
2026-01-161850PUT0 050.67TRUE00
2026-01-161900PUT0 050.46TRUE00
2026-01-161950PUT0 049.83TRUE00
2026-01-162000PUT0 049.86TRUE00
2026-01-162100PUT0 049.31TRUE00
2026-01-162200PUT0 048.77TRUE00
2026-01-162300PUT0 047.83TRUE00
2026-01-162400PUT0 048.05TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm